Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nipsnap homolog 1 (NIPSNAP1) is a highly conserved mitochondrial protein containing a unique NIPSNAP domain that binds molecules such as NADH, NADPH, NAD, NADP, and ATP, suggesting a role as a sensor of mitochondrial metabolic state[1][3]. NIPSNAP1 is crucial for maintenance of mitochondrial health, regulating processes such as mitophagy (the removal of damaged mitochondria) in partnership with proteins like PARKIN and autophagy-related proteins (LC3/GABARAP, ALFY, P62, NBR1, TAX1BP1)[1][3]. It interacts with enzymes controlling core cellular metabolism, such as the pyruvate dehydrogenase complex and branched-chain α-keto acid dehydrogenase, indicating a modulatory role in metabolic flux between glycolysis and oxidative phosphorylation[1][3][4]. NIPSNAP1 also binds a variety of pharmacologically relevant compounds (clarithromycin, finasteride, trichostatin A), making it relevant for studies on drug-mitochondria interactions[1][5]. Although named for “nitrophenylphosphatase” and “SNAP25-like,” NIPSNAP1 contains neither domain; the name reflects gene neighborhood rather than structural homology[1]. Disease associations include neurodegenerative conditions (notably, Parkinson’s disease through effects on mitophagy), cancer (altered metabolism/mitophagy), and pain transmission[2][3]. NIPSNAP1 is most strongly expressed in mitochondria-rich tissues such as kidney and pancreatic islets in humans[6]. It is not a classical therapeutic target (i.e., receptor/enzyme), but recent studies indicate direct drug interactions, making it an emerging interest for drug discovery and mitochondrial functional studies[1][5][7].
Direct binding and regulation by small molecules/drugs (e.g., clarithromycin) Modulation of mitophagy/autophagy pathways (indirect effects) Regulation of mitochondrial metabolism via protein-protein interaction (e.g., pyruvate dehydrogenase complex)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nipsnap homolog 1 (NIPSNAP1).